Ob/Gyn Medical News about Epithelial Ovarian Cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Weekly Topotecan and Daily Thalidomide in Patients with Recurrent Epithelial Ovarian Cancer: A Report of 2 Cases
The Journal of Reproductive Medicine, 09/11/09

Phippen NT et al. – The authors report describes a well–tolerated, novel use of a weekly topotecan and daily thalidomide regimen. This regimen may be a reasonable alternative to the standard regimen of day 1–5 topotecan and thalidomide and should be further evaluated.

<< Previous
Are Obstetricians Following Best-Practice Guidelines for...

Next >>
Wrapping of the legs versus phenylephrine for reducing...